For research use only. Not for therapeutic Use.
Apostatin-1(Cat No.:I043468)is an investigational peptide or small molecule under study for its potential therapeutic applications, particularly in cancer research. It is designed to target specific proteins or pathways involved in tumor growth, metastasis, and cell survival. By modulating these pathways, Apostatin-1 may inhibit cancer cell proliferation and promote apoptosis (programmed cell death). Ongoing research is focused on evaluating its efficacy and safety in preclinical or clinical trials, with the goal of offering a novel treatment option for various cancers, including those that are resistant to traditional therapies.
CAS Number | 2559703-06-7 |
Synonyms | N-cycloheptyl-2-[(1-methyl-4,5-dihydroimidazol-2-yl)sulfanyl]-2-phenylacetamide |
Molecular Formula | C19H27N3OS |
Purity | ≥95% |
IUPAC Name | N-cycloheptyl-2-[(1-methyl-4,5-dihydroimidazol-2-yl)sulfanyl]-2-phenylacetamide |
InChI | InChI=1S/C19H27N3OS/c1-22-14-13-20-19(22)24-17(15-9-5-4-6-10-15)18(23)21-16-11-7-2-3-8-12-16/h4-6,9-10,16-17H,2-3,7-8,11-14H2,1H3,(H,21,23) |
InChIKey | OXBMBNASDMMXSA-UHFFFAOYSA-N |
SMILES | CN1CCN=C1SC(C2=CC=CC=C2)C(=O)NC3CCCCCC3 |